How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician
Júlio Maria Fonseca Chebli, Liliana Andrade Chebli, Division of Gastroenterology, Department of Medicine, Inflammatory Bowel Disease Center, Federal University of Juiz de Fora, Juiz de Fora 36036-900, MG, Brazil
Natália Sousa Freitas Queiroz, Adérson Omar Mourão Cintra Damião, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo 05403-000, SP, Brazil
Márcia Henriques de Magalhães Costa, Department of Clinical Medicine, Fluminense Federal University, Rio de Janeiro 24210-200, RJ, Brazil
Rogério Serafim Parra, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14048-900, SP, Brazil
Author contributions: All authors equally contributed to data collection, data interpretation, and literature review; all authors wrote the paper and contributed to critical revision of the manuscript; all authors granted final approval of the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work were appropriately investigated and resolved.
Conflict-of-interest statement: Parra RS has received fees for serving as a speaker and/or an advisory board member for AbbVie, Ferring Pharmaceuticals, Janssen, and Takeda. Chebli JMF has received fees for serving as a speaker and/or an advisory board member for Abbott, AbbVie, Janssen, and Takeda. Chebli LA has received fees for serving as a speaker for Janssen and Takeda. Queiroz NSF reports receiving consulting and lecture fees from Janssen, Takeda, and Abbvie. Damião AOMC has received fees for serving as a speaker and/or an advisory board member for Takeda, Abbvie, Pfizer, Janssen, Ferring, and Natulab.
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rogério Serafim Parra, MD, PhD, Assistant Professor, Staff Physician, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto 14048-900, SP, Brazil. email@example.com
Received: January 24, 2021
Peer-review started: January 24, 2021
First decision: February 10, 2021
Revised: February 11, 2021
Accepted: March 11, 2021
Article in press: March 11, 2021
Published online: March 21, 2021